Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience
ConclusionR–MTX–ARA-C followed by autologous stem cell transplantation seems a promising strategy with high response rates in PCNSL.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Hematology | Lymphoma | Methotrexate | Middle East Health | Primary CNS Lymphoma | Rituxan | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants